Compound ID | 765

AM-3005

Class: Mutilin-quinolone hybrid

Spectrum of activity: Gram-negative
Details of activity: Inhibits protein synthesis and bacterial Type II topoisomerases. Active against MRSA. Spontaneous mutants were identified which showed a mutation in rplV gene which encodes the L22 ribosomal protein.
Institute where first reported: Kyorin Pharamaceutical Co., Ltd., Japan
Year first mentioned: 2008
Highest developmental phase: Preclinical
Development status: Inactive

AntibioticDB is supported by GARDP.

If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.